Hyperammonemia with Valproic Acid: Colonic Ischemia Associated with “Triptan” Use Visual Side Effects with Pegylated Interferon: Alopecia Areata with Infliximab: Adverse Effects Seen with Medications Used for Irritable Bowel Syndrome
Restricted accessResearch articleFirst published online November, 2004
Hyperammonemia with Valproic Acid: Colonic Ischemia Associated with “Triptan” Use Visual Side Effects with Pegylated Interferon: Alopecia Areata with Infliximab: Adverse Effects Seen with Medications Used for Irritable Bowel Syndrome
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
In 2004, ISMP is celebrating the 10th anniversary of its incorporation as a nonprofit organization. The Institute represents more than 20 years of experience in helping health care practitioners keep patients safe, and continues to lead efforts to improve the medication use process.
Get full access to this article
View all access options for this article.
References
1.
ShusterJ.ISMP adverse drug reactions: Valproate and hyperammonemia.Hosp Pharm.1999; 34(12): 1389–90.
2.
ShusterJ.ISMP adverse drug reactions: More on valproate-induced hyperammonemia.Hosp Pharm.2000; 35(4): 362–3.
3.
McCallM., BourgeoisJ.A.Valproic acid-induced hyperammonemia: A case report.J Clin Psychopharmacol.2004; 24(5): 521–6.
4.
MalletL., BabinS., MoraisJ.A.Valproic-acid-induced hyperammonemia and thrombocytopenia in an elderly woman.Ann Pharmacother.2004; 38: 1643–47.
WillsonR.A.Visual side effects of pegylated interferon during therapy for chronic hepatitits C infection.J Clin Gastroenterol.2004; 38(8): 717–22.
7.
EttefaghL., NedorostS., MirmiraniP.Alopecia areata in a patient using infliximab: New insights into the role of tumor necrosis factor on human hair follicles [letter].Arch Dermatol.2004; 140(8): 1012.